Cas12a and Lateral Flow Strip-Based Test for Rapid and Ultrasensitive Detection of Spinal Muscular Atrophy.
Spinal muscular atrophy (SMA) is characterized by severe lethality and irreversible progression. Early diagnosis of SMA is of more practical significance with the emergence of effective therapy. However, existing techniques to identify SMA patients rely on cumbersome instruments, hindering their accessibility and application. An SMA-Cas12a-strip assay was developed with the integration of Cas12a-based nucleic acid detection, isothermal amplification, and lateral flow strip. The analytical performance of the assay was assessed with clinical samples. To explore its extensible utility, various specimens were tested. Validated with 168 clinical samples, the sensitivity and specificity of the SMA-Cas12a-strip assay were both 100%. The minimum detectable concentration of genomic DNA containing the target gene achieved 526 aM. The assay was compatible with specimens from several sources, and the turnaround time could be within 1.5 h. We developed a simple, cost-effective, and highly sensitive and specific assay to detect SMA patients. With little and field-portable equipment, the assay holds great promise in the detection of SMA patients, particularly in low-resource regions.
['Zhang|Chunhua|C|', 'Li|Zhuo|Z|', 'Chen|Miaomiao|M|', 'Hu|Zhiqing|Z|', 'Wu|Lingqian|L|', 'Zhou|Miaojin|M|', 'Liang|Desheng|D|']
D015374:Biosensing Techniques D064113:CRISPR-Cas Systems D006801:Humans D009134:Muscular Atrophy, Spinal
Cas12a detection spinal muscular atrophy lateral flow strip